Quality and effectiveness of diabetes care for a group of patients in Colombia

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 26, Issue 6, 2009, Pages 529-535

  Machado Alba, Jorge E ^a,b   Moncada Escobar, Juan C ^b   Gaviria, Henry ^c  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^b AUDIFARMA S A   (Colombia)

^c Hospital Universitario San Jorge   (Colombia)

Author keywords

Colombia; Diabetes mellitus; Effectiveness; Quality of health care

Indexed keywords

ANTIBIOTIC RESISTANCE; DIABETES; DRUG; HEALTH IMPACT; HEMOGLOBIN; LIPID; METABOLISM; RISK FACTOR; SERUM;

COLOMBIA;

EID: 77249090922     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892009001200008     Document Type: Article

References (27)

1. Pan American Health Organization. Diabetes in the Americas. Epidemiol Bull. 2001;22(2): 1-3.
2. Barceló A, Daroca M, Ribera R, Duarte E, Zapata A, Vohra M. Diabetes in Bolivia. Rev Panam Salud Publica. 2001;10(5): 318-23.
3. Aschner P. Diabetes trends in Latin America. Diabetes Metab Res Rev. 2002;18(Suppl 3): S27-31.
4. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28(2): 337-42.
5. Chiasson J-L, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and betacell function. Diabetes. 2004;53(Suppl 3): S34-8.
6. Gagliardino JJ, de la Hera M, Siri F; Grupo de Investigación de la Red QUALIDIAB. Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Salud Publica. 2001;10(5): 309-17.
7. Clarke PM, Gray AM, Briggs A, Stevens RJ, Matthews DR, Holman RR. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia. 2005;48(5): 868-77.
8. Asociación Latinoamericana de Diabetes. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Rev Asoc Latinoam Diabetes. 2000;8(Supl 1): S101-68.
9. International Diabetes Federation, Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussels: IDF. p. 8-74.
10. Fioretto P, Solini A. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol. 2005;16(Suppl 1): S18-21.
11. Ministerio de Salud Publica (CO). Consejo Nacional de Seguridad Social en Salud. Acuerdo 228 de 2002. Bogotá: MSP; 2002 [cited 2006 May 31]. Diario Oficial de Colombia. 26 Jun (no. 44847). Available from: http://www.col.ops-oms.org/medicamentos/Documentos/ac228-02.htm.
12. Machado Alba JE, Moncada Escobar JC, Mesa Escobar G. Patrones de prescripción de antidiabéticos en un grupo de pacientes colombianos. Rev Panam Salud Publica. 2007;22 (2): 124-31.
13. Erdmann E. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. Int J Cardiol. 2006;107(2): 147-53. Epub 2005 Jun 22.
14. Duffau G. Tamaño muestral en estudios biomédicos. Rev Chil Pediatr. 1999;70(4): 314-24.
15. Liebl A, Mata M, Eschwège E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002;45(Suppl 7): S23-8. Epub 2002 Jun 19.
16. Qaseem A, Vijan S, Snow V, Cross T, Weiss K, Owens D. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med. 2007; 147(6): 417-22.
17. Jerums G, MacIsaac RJ. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol. 2002;1(3): 163-73.
18. Resnick HE, Bardsley J, Foster GL, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002. Diabetes Care. 2006;29(3): 531-7.
19. Lebovitz HE. Oral antidiabetic agents: 2004. Med Clin North Am. 2004;88(4): 847-63.
20. Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, Brown AF, et al. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med. 2006;145(2): 107-16.
21. Varroud-Vial M, Charpentier G, Vaur L, Attali JR, Balarac N, Cervantes P, et al. Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study. Diabetes Metab. 2001;27(6): 666-74.
22. Spitz A, Kanani H. Change in HbA1c as a measure of quality of diabetes care. Diabetes Care. 2006;29(5): 1183-4.
23. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006(3);29: 725-31.
24. Isaza CA, Moncada JC, Mesa G, Osorio FJ. Efectividad del tratamiento antihipertensivo en una muestra de pacientes colombianos. Biomédica. 2004;24(3): 273-81.
25. Bloomgarden ZT. Glycemic treatment: control of glycemia. Diabetes Care. 2004;27(5): 1227-34.
26. Machado JE, Moncada JC, Mesa G. Patrones de prescripción de antilipémicos en un grupo de pacientes colombianos. Rev Panam Salud Publica. 2008;23(3): 179-87.
27. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296 (22): 427-40.